MKI67 and breast carcinoma: A decrease in Ki‐67 and an increase in E‐cadherin in hesperidin‐treated mice (alone and in combination with doxorubicin) indicate that hesperidin could be considered as a suitable agent with inhibitory effects on the proliferative and migratory properties of breast cancer cells.